The ELDORADO (Eligard, Docetaxel and Radiotherapy) Study: A Phase II Study of Chemo - Hormonal Therapy and Radiation in High Risk Prostate Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel (Primary) ; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms ELDORADO
- 19 Mar 2014 Biomarkers information updated
- 29 Oct 2013 Planned end date changed from 1 Jul 2014 to 1 Feb 2017 as reported by ClinicalTrials.gov.
- 05 Mar 2012 Planned End Date changed from 1 Jul 2012 to 1 Jul 2014 as reported by ClinicalTrials.gov.